News
1h
News Medical on MSNWhy skin shame matters more than symptoms in chronic skin conditionsA new study in Scientific Reports reveals that skin shame is a key psychological burden for people with atopic dermatitis and ...
Galderma has kicked off an ad campaign to show how its Nemluvio can empower people to rule over itchy eczema. Aiming to grow ...
Ninety-five percent (95%) of U.S. dermatology providers surveyed agreed moderate-to-severe chronic hand eczema (CHE) has a ...
On Tuesday morning, Galderma launched its Scratch Resistance campaign to highlight one of the most difficult symptoms of ...
Oatmeal baths are one of the oldest tricks in the book for soothing eczema and skin rashes.This writer tested the eczema ...
The viral content creator tells all about her severe eczema and why she supplements her “from scratch” recipes with Cetaphil.
Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.
Data from the BroADen Phase 1b atopic dermatitis (AD) patient trial expected to be reported in 4Q25 Completed SAD/MAD dosing in KT-621 Phase 1 healthy volunteer trial with data to be reported in June ...
Recent clinical studies have started showing the benefits of using vitamin B12 cream to help manage dermatitis. Vitamin B12 ...
AD is a growing market with an impressive pipeline of new products from current and future players in the field.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results